Immune Responses to Recombinant Adenoviruses As Gene Therapy Vectors and COVID-19 Vaccines: A Two-Edged Sword

Hum Gene Ther. 2021 Jul;32(13-14):645-646. doi: 10.1089/hum.2021.29169.trf.
No abstract available

Publication types

  • News
  • Comment

MeSH terms

  • Adenoviridae* / genetics
  • Adenoviridae* / immunology
  • COVID-19 Vaccines
  • COVID-19*
  • Genetic Therapy
  • Genetic Vectors / genetics
  • Humans
  • Immunity
  • SARS-CoV-2

Substances

  • COVID-19 Vaccines